Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 27, 2023 08:30 ET | Source: CVRx, Inc.

CVRx to Present at the Canaccord Genuity 43rd Annual Growth Conference

MINNEAPOLIS, July 27, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
July 25, 2023 16:15 ET | Source: CVRx, Inc.

CVRx Reports Second Quarter 2023 Financial and Operating Results

MINNEAPOLIS, July 25, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
July 11, 2023 16:30 ET | Source: CVRx, Inc.

CVRx to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call on July 25th, 2023

MINNEAPOLIS, July 11, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...
June 22, 2023 16:30 ET | Source: CVRx, Inc.

CVRx Set to Join Russell 2000 & 3000 Indexes

MINNEAPOLIS, June 22, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
May 25, 2023 08:30 ET | Source: CVRx, Inc.

CVRx to Present at the William Blair 43rd Annual Growth Stock Conference

MINNEAPOLIS, May 25, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
April 27, 2023 16:15 ET | Source: CVRx, Inc.

CVRx Reports First Quarter 2023 Financial and Operating Results

MINNEAPOLIS, April 27, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
April 20, 2023 16:30 ET | Source: CVRx, Inc.

CVRx to Report First Quarter 2023 Financial and Operating Results and Host Conference Call on April 27th, 2023

MINNEAPOLIS, April 20, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...
March 21, 2023 11:02 ET | Source: CVRx, Inc.

Totality of Evidence from BeAT-HF Study Shows CVRx’s Barostim Provides Long-term Benefits for Patients with Heart Failure

MINNEAPOLIS, March 21, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...
March 16, 2023 08:30 ET | Source: CVRx, Inc.

CVRx Reiterates Plans to Discuss the Preliminary Results from the Post-Market Phase of the BeAT-HF Trial at THT 2023 and Schedules a Conference Call

MINNEAPOLIS, March 16, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative...
February 21, 2023 07:00 ET | Source: CVRx, Inc.

CVRx Reports Preliminary Results of the BeAT-HF Post-Market Randomized Clinical Trial

MINNEAPOLIS, Feb. 21, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right